Ensign Peak Advisors, Inc 4 D Molecular Therapeutics, Inc. Transaction History

Ensign Peak Advisors, Inc

  • $54.2 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$6.96 - $11.48 $31,320 - $51,660
4,500 Added 167.91%
7,180 $58,000
Q1 2022

May 16, 2022
BUY
$13.16 - $22.64 $6,185 - $10,640
470 Added 21.27%
2,680 $41,000
Q4 2021

Feb 11, 2022
BUY
$19.56 - $32.94 $43,227 - $72,797
2,210 New
2,210 $48,000

Others Institutions Holding FDMT

# of Institutions
157
Shares Held
50.3M
Call Options Held
718K
Put Options Held
370K
View Full List

About 4D Molecular Therapeutics, Inc.

FDMT Quotes by TradingView
  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $675M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track Ensign Peak Advisors, Inc Portfolio

Follow Ensign Peak Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email